hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways

Journal of Biological Chemistry

Volumn 282, Issue 7, 2007, Pages 4943-4950

  Li, Hongzhe ^a   Wang, Xiaojian ^b   Li, Nan ^c   Qiu, Jianming ^a   Zhang, Yuanyuan ^a   Cao, Xuetao ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b Tsinghua University   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC MOLECULES; BINDING PROTEINS; BREAST CANCER TREATMENT; THERAPEUTIC AGENTS;

BINDING SITES; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN ENGINEERING; TUMORS;

CELL DEATH;

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1 INHIBITOR; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 4; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; CASPASE 8; DNA BINDING PROTEIN; ENHANCER BINDING PROTEIN AP 4; ENHANCER-BINDING PROTEIN AP-4; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TNFSF10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BREAST NEOPLASMS; CASPASE 8; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MALE; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOGENE PROTEIN V-AKT; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTORS;

EID: 33947502315     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M609494200     Document Type: Article

References (32)

1. Ghosh, P. M., Malik, S. N., Bedolla, R. G., Wang, Y., Mikhailova, M., Prihoda, T. J., Troyer, D. A., and Kreisberg, J. I. (2005) Endocr. Relat. Cancer 12, 119-134
2. Festuccia, C., Muzi, P., Millimaggi, D., Biordi, L., Gravina, G. L., Speca, S., Angelucci, A., Dolo, V., Vicentini, C., and Bologna, M. (2005) Endocr. Relat. Cancer 12, 983-998
3. Uzgare, A. R., Kaplan, P. J., and Greenberg, N. M. (2003) Prostate 55, 128-139
4. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F., Jr., and Weber, M. J. (1999) Cancer Res. 59, 279-2845
5. Malik, S. N., Brattain, M., Ghosh. P. M., Troyer. D. A., Prihoda. T., Bedolla. R., and Kreisberg. J. I. (2002) Clin. Cancer Res. 8, 1168-1171
6. Kreisberg, J. I., Malik, S. N., Prihoda, T. J., Bedolla, R. G., Troyer, D. A., Kreisberg, S., and Ghosh, P. M. (2004) Cancer Res. 64, 5232-5236
7. Wagner, K. W., Engels, I. H., and Deveraux, Q. L. (2004) J. Biol. Chem. 279, 35047-35052
8. Suliman, A., Lam, A., Datta, R., and Srivastava, R. K. (2001) Oncogene 20, 2122-2133
9. Broaddus, V. C., Dansen, T. B., Abayasiriwardana, K. S., Wilson, S. M., Finch, A. J., Swigart, L. B., Hunt, A. E., and Evan, G. I. (2005) J. Biol. Chem. 280, 12486-12493
10. Nesterov, A., Lu, X., Johnson, M., Miller, G. J., Ivashchenko, Y., and Kraft, A. S. (2001) J. Biol. Chem. 276, 10767-10774
11. Thakkar, H., Chen, X., Tyan, F., Gim, S., Robinson, H., Lee, C., Pandey, S. K., Nwokorie, C., Onwudiwe, N., and Srivastava, R. K. (2001) J. Biol. Chem. 276, 38361-38369
12. Oka, N., Nakahara, S., Takenaka, Y., Fukumori, T., Hogan, V., Kanayama, H. O., Yanagawa, T., and Raz, A. (2005) Cancer Res. 65, 7546-7553
13. Medema, R. H., Kops, G. J., Bos, J. L., and Burgering, B. M. (2000) Nature 404, 782-787
14. Graff, J. R., Konicek, B. W., McNulty, A. M., Wang, Z., Houck, K., Allen, S., Paul, J. D., Hbaiu, A., Goode, R. G., Sandusky, G. E., Vessella, R. L., and Neubauer, B. L. (2000) J. Biol. Chem. 275, 24500-24505
15. Xiao, D., and Singh, S. V. (2006) Carcinogenesis 27, 533-540
16. Hu, W. H., Johnson, H., and Shu, H. B. (1999) J. Biol. Chem. 274, 30603-30610
17. Sah, N. K., Munshi, A., Kurland, J. F., McDonnell, T. J., Su, B., and Meyn, R. E. (2003) J. Biol. Chem. 278, 20593-20602
18. Wang, X., Li, N., Liu, B., Sun, H., Chen, T., Li, H., Qiu, J., Zhang, L., Wan, T., and Cao, X. (2004) J. Biol. Chem. 279, 45855-45864
19. Wang, X., Li, N., Li, H., Liu, B., Qiu, J., Chen, T., and Cao, X. (2005) Clin. Cancer Res. 11, 7545-7553
20. Yu, R., Mandlekar, S., Ruben, S., Ni, J., and Kong, A. N. (2000) Cancer Res. 60, 2384-2389
21. Ma, Y., Lakshmikanthan, V., Lewis, R. W., and Kumar, M. V. (2006) Mol. Cancer Ther. 5, 170-178
22. Thorburn, A. (2004) Cell Signal. 16, 139-144
23. Corallini, F., Milani, D., Nicolin, V., and Secchiero, P. (2006) Leuk. Lymphoma 47, 1459-1468
24. Kim, T. H., Zhao, Y., Barber, M. J., Kuharsky, D. K., and Yin, X. M. (2000) J. Biol. Chem. 275, 39474-39481
25. Werner, A. B., de, V. E., Tait, S. W., Bontjer, I., and Borst, J. (2002) J. Biol. Chem. 277, 40760-40767
26. Yoon, G., Kim, H. J., Yoon, Y. S., Cho, H., Lim, I. K., and Lee, J. H. (2002) Biochem. J. 366, 613-621
27. Li, C. H., Tzeng, S. L., Cheng, Y. W., and Kang, J. J. (2005) J. Biol. Chem. 280, 26193-26199
28. Sinha, D., Bannergee, S., Schwartz, J. H., Lieberthal, W., and Levine, J. S. (2004) J. Biol. Chem. 279, 10962-10972
29. Liu, L., Xie, Y., and Lou, L. (2006) Eur. J. Cell Biol. 85, 367-374
30. Zhang, L., and Fang, B. (2005) Cancer Gene Ther. 12, 228-237
31. Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z. Q., Ma, X. L., Shelley, S. A., Jove, R., Tsichlis, P. N., Nicosia, S. V., and Cheng, J. Q. (2001) Am. J. Pathol. 159, 431-437
32. Zhang, M., Fang, X., Liu, H., Wang, S., and Yang, D. (2007) Biochem. Pharmacol. 73, 15-24